Cerner, Mortara Introduce CareAware Waveform Management

KANSAS CITY, Mo., Feb. 12, 2015 — Cerner Corp. (Nasdaq:CERN), one of the largest health information technology suppliers, and development partner Mortara Instrument, a leading U.S. manufacturer of diagnostic cardiology instrumentation, including multi-parameter patient monitoring, have joined together to introduce CareAware Waveform Management(TM).

The new solution displays waveforms and other physiological data from patient monitoring systems and integrates them into the Electronic Health Record (EHR).

"This solution is one of the final steps toward creating a fully digital hospital," said Stephanie Rogers, RN-BC and director of critical care at Cerner. "Although hospitals are working toward a fully integrated digital care process, today they are still subjected to printing rolls of paper strips to monitor patient waveforms. We expect the integration of physiological waveforms and data into the electronic health record will lead to enhanced decision-making and improved patient outcomes by streamlining documentation and viewing of waveforms in the context of other relevant patient information."

With CareAware Waveform Management, clinicians will be able to view physiologic waveforms, data and alarms on devices with access to the patient record. Caregivers will be able to monitor patient waveforms in the context of other relevant patient information. The solution will help streamline documentation by enabling clinicians to electronically view, measure, annotate and save waveform strips to the EHR, eliminating one of the final pieces of paper in the hospital setting.

"Bringing Mortara's waveform management capabilities to the Cerner solution reflects our vision of fully integrating medical devices into ever more connected EHR systems," said Dr. Justin Mortara, CEO of Mortara. "We are confident that, by extending waveform capabilities to CareAware, clinicians will realize easier access to relevant data."

The University of Missouri (MU) Health Care and Cerner leveraged their collaborative relationship with the Tiger Institute to alpha test the new waveform technology with live data.

"MU Health Care is committed to providing high-quality patient care throughout our clinical enterprises," said Bridgett Robbins, RN, clinical manager, MU Health Care. "As the alpha client of Cerner's CareAware Waveform Management solution, this partnership helps us move toward our goal of implementing innovative and progressive processes to provide superior care."

To learn more about CareAware Waveform Management, visit www.cerner.com/waveforms.

About Cerner

Cerner's health information technologies connect people, information and systems at more than 18,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs.
Cerner's mission is to contribute to the improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at cerner.com/blog, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner.

As of February 2, 2015, Cerner Corporation acquired Siemens Health Services. Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All other non-Cerner marks are the property of their respective owners.

About Mortara Instrument

Mortara Instrument, Inc. was founded 30 years ago and today is a recognized technology leader in the world of ECG. Mortara's global headquarters is located in Milwaukee, Wisconsin with operations in Australia, Germany, Italy, the Netherlands, and the United Kingdom.
Mortara is distinguished in the field of non-invasive cardiology for innovations that are the core of the company's complete line of ECG products including electrocardiographs, cardiac stress exercise and rehabilitation systems, Holter systems, data warehousing solutions, and cardiology monitoring systems. The company manufactures and distributes its ECG devices and related technologies worldwide. Mortara's market leadership is a result of its substantial investment in R & D which has fueled the introduction of many new Mortara products uniquely positioned to benefit customers in their everyday use of diagnostic ECG devices. To learn more about Mortara Instrument and its expanding product portfolio visit www.mortara.com.